ELIXIRGEN THERAPEUTICS, INC.

Amendment
CIK: 0001744333·Biotechnology·DELAWARE·Filed: Aug 17, 2020
Total Offering

$5,706,889

Amount Sold

$5,706,889

Investors

3

First Sale

Nov 19, 2019

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
AKIHIRO KO
Related Person
MINORU KO
Related Person
Naonori Kurokawa
Related Person
Maiko Katadae
Related Person

Company

ELIXIRGEN THERAPEUTICS, INC.

855 N. WOLFE ST.

BALTIMORE, MD, 21205

443-869-5420

SEC Filing

0001744333-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
ELIXIRGEN THERAPEUTICS, INC. Form D Filing — $5,706,889 | FilingFlow